Because GBM cells abundantly express TN-C, MMP-mediated release of the TNIIIA2 region from TN-C appears to be a key event underlying the expression of malignancy in GBM cells, through its ability to activate β1 integrins. The gene discussed is TNC; the disease is glioblastoma.